PGFC
Peapack-Gladstone Financial Corp’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Buy |
6,973
+200
| +3% | +$9.72K | ﹤0.01% | 536 |
|
|
2025
Q1 | $230K | Hold |
6,773
| – | – | ﹤0.01% | 615 |
|
|
2024
Q4 | $266K | Hold |
6,773
| – | – | ﹤0.01% | 590 |
|
|
2024
Q3 | $318K | Buy |
6,773
+130
| +2% | +$6.1K | ﹤0.01% | 561 |
|
|
2024
Q2 | $359K | Hold |
6,643
| – | – | 0.01% | 535 |
|
|
2024
Q1 | $453K | Buy |
6,643
+2,053
| +45% | +$140K | 0.01% | 499 |
|
|
2023
Q4 | $288K | Hold |
4,590
| – | – | ﹤0.01% | 577 |
|
|
2023
Q3 | $208K | Hold |
4,590
| – | – | ﹤0.01% | 630 |
|
|
2023
Q2 | $258K | Buy |
+4,590
| New | +$258K | ﹤0.01% | 595 |
|